Seyfizadeh Narges, Kazemi Tohid, Farhoudi Mehdi, Aliparasti Mohammad Reza, Sadeghi-Bazargani Homayoun, Almasi Shohreh, Babaloo Zohreh
Neuroscience Research Center, Imam Reza Teaching Hospital, School of Medicine, Tabriz University of Medical Sciences Tabriz, Iran ; Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences Tabriz, Iran ; Immunology Research Center, Faculty of Medicine, Tabriz University of Medical Sciences Tabriz, Iran.
Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences Tabriz, Iran ; Immunology Research Center, Faculty of Medicine, Tabriz University of Medical Sciences Tabriz, Iran.
Am J Clin Exp Immunol. 2014 Dec 5;3(3):124-9. eCollection 2014.
MS is an autoimmune disease and interleukin 13 (IL-13) has been proposed to be an important neuroprotective mediator in MS. Because of plausible effect of single nucleotide polymorphisms (SNPs) in expression level or biological activity of any cytokine, we sought to investigate association of IL-13 SNPs, C-1112T, A-1512C and G+2044A, with risk to MS. Sixty-eight RRMS patients and 110 healthy controls were involved in this study. After extraction of genomic DNA, frequency of genotypes and alleles were determined by PCR-RFLP and data were analyzed statistically. Results showed significant higher frequency of CC, CC, and AA genotypes and C, C, and A alleles of -1112CT, -1512AC and +2044GA SNPs respectively, in patients group. There was significant association between -1112C allele with onset age of MS. No significant association was seen between any of genotypes or alleles with expanded disability status scale (EDSS) of patients. Our findings showed significant association between three studied SNPs of IL-13 with susceptibility to MS in Iranian patients. More studies should be done on other IL-13 SNPs, and also polymorphisms of IL-13 receptor and other cytokines to determine the exact role of SNPs in protecting or predisposing of individuals for MS.
多发性硬化症(MS)是一种自身免疫性疾病,白细胞介素13(IL-13)被认为是MS中一种重要的神经保护介质。由于单核苷酸多态性(SNP)对任何细胞因子的表达水平或生物学活性可能有影响,我们试图研究IL-13的SNP,即C-1112T、A-1512C和G+2044A与MS发病风险的关联。本研究纳入了68例复发缓解型多发性硬化症(RRMS)患者和110名健康对照。提取基因组DNA后,通过聚合酶链反应-限制性片段长度多态性(PCR-RFLP)确定基因型和等位基因频率,并对数据进行统计学分析。结果显示,患者组中-1112CT、-1512AC和+2044GA SNP的CC、CC和AA基因型以及C、C和A等位基因的频率分别显著更高。-1112C等位基因与MS的发病年龄之间存在显著关联。在患者的任何基因型或等位基因与扩展残疾状态量表(EDSS)之间未发现显著关联。我们的研究结果表明,在伊朗患者中,IL-13的三个研究SNP与MS易感性之间存在显著关联。应针对其他IL-13 SNP以及IL-13受体和其他细胞因子的多态性开展更多研究,以确定SNP在个体对MS的保护或易感性中的确切作用。